Search

AstraZeneca PLC

Closed

SectorHealthcare

189.19 1.74

Overview

Share price change

24h

Current

Min

185.42

Max

186.68

Key metrics

By Trading Economics

Income

599M

3.1B

Sales

609M

16B

P/E

Sector Avg

26.39

51.78

EPS

2.79

Dividend yield

1.73

Profit margin

19.23

Employees

96,100

EBITDA

741M

5.9B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+16.74% upside

Dividends

By Acuity

Dividend yield

Sector Avg

1.73%

1.96%

Next Earnings

9 Feb 2027

Market Stats

By TradingEconomics

Market Cap

27B

289B

Previous open

187.45

Previous close

189.19

AstraZeneca PLC Chart

Past performance is not a reliable indicator of future results.

Related News

7 Nov 2026, 00:02 UTC

News

Pfizer Inc. shares declined modestly during after-market hours, continuing a trend of lower performance and remaining below the 20-day moving average.

7 Nov 2026, 00:02 UTC

News

Opendoor Technologies Inc. shares rose in after-market trading, reflecting a strong performance amid broader market strength.

7 Nov 2026, 00:02 UTC

News

JP Morgan maintains Overweight rating on Cloudflare, Inc. and raises price target to $375 in a report published today.

7 Nov 2026, 00:02 UTC

News

Hawaiian Electric Industries reported Q3 2026 net income of $35 million, up from $31 million a year ago, with revenue rising to $1.01 billion.

7 Nov 2026, 00:02 UTC

News
Social Media

Gogo Inc. shares advanced during after-market hours amid a significant short squeeze, with trading volumes approximately 20 times the normal level.

7 Nov 2026, 00:02 UTC

News

A class action lawsuit has been filed against AppLovin Corporation by Pomerantz LLP, alleging false statements about AI model development and following disappointing quarterly results.

7 Nov 2026, 00:01 UTC

News

UBS upgraded JinkoSolar Holding Co., Ltd. to a Buy rating and set a price target of $17 in a report published after market hours.

7 Nov 2026, 00:01 UTC

News

Shares gain in after-market trading despite negative outlook revision.

6 Nov 2026, 23:51 UTC

News

UBS maintains a Sell rating on Dropbox Inc and raises its price target to $26, contributing to the stock's after-market decline.

6 Nov 2026, 23:51 UTC

News

Viridian Therapeutics will host a conference call on November 9, 2026, to present data from its VRDN-008 phase 1 clinical trial and discuss development plans.

6 Nov 2026, 23:41 UTC

News

Citigroup reaffirms Buy rating on Cummins Inc and raises price target to $525, with shares advancing in after-market trading.

6 Nov 2026, 23:36 UTC

News

Ingredion Inc reported Q3 2026 net sales of $1.79 billion and net income of $142 million, while shares traded higher in after-market hours.

6 Nov 2026, 23:26 UTC

News

Citigroup maintains Neutral rating on HubSpot, lowering its price target to $230, reflecting ongoing assessment of the company's performance.

6 Nov 2026, 23:26 UTC

News

Citigroup maintains its Buy rating on Aptiv PLC and raises its price target to $68, contributing to a modest rebound in after-market trading.

6 Nov 2026, 23:16 UTC

News

UBS upgraded JinkoSolar Holding Co., Ltd. to Buy and set a price target of $17, reflecting a positive outlook on the company's performance.

6 Nov 2026, 23:12 UTC

News

JP Morgan maintains Overweight rating on Cloudflare, Inc. and raises price target to $375, a development published shortly before Friday's market close.

6 Nov 2026, 23:11 UTC

News

Truist Securities raises Insulet Corporation's price target to $160.00 from $153.00 while maintaining a Hold rating, as shares decline in after-market trading.

6 Nov 2026, 23:11 UTC

News

Lemonade Inc filed a mixed shelf registration statement for potential issuance of securities, contributing to its modest price increase in after-market trading.

6 Nov 2026, 23:11 UTC

News

Boston Scientific shares advanced in after-market trading, recovering from three sessions of declines, despite S&P Global Ratings revising its outlook to negative.

6 Nov 2026, 23:06 UTC

News

Pfizer Inc. shares traded modestly lower during after-market hours on Friday, continuing a downward trend that began shortly after the market closed.

6 Nov 2026, 23:06 UTC

Social Media
News

NVIDIA Corporation's shares advanced after a rebound in the technology sector, aligning with broader gains across Wall Street amid renewed interest in AI-related stocks.

6 Nov 2026, 23:06 UTC

News

NIO Inc. shares are trading lower in after-market hours as the CEO calls for national limits on electric vehicle weight in China, citing infrastructure concerns.

6 Nov 2026, 23:06 UTC

News

U.S. State Department approves potential $1.08 billion sale of UH-60M Blackhawk helicopters to Mexico, enhancing Lockheed Martin's position in the defense sector.

6 Nov 2026, 23:06 UTC

News

Citigroup maintains a Neutral rating on Wendy's Co and raises its price target to $8, reflecting the firm's assessment of the company's performance.

6 Nov 2026, 23:06 UTC

News

Citigroup maintains its Buy rating on Unity Software Inc. and raises the price target to $59, reflecting confidence in the company's growth prospects.

6 Nov 2026, 23:02 UTC

News

Hawaiian Electric Industries reports Q3 2026 net income of $35 million, boosted by $64 million in pre-tax gains, with revenue rising to $1.01 billion.

6 Nov 2026, 23:02 UTC

News
Correlated Moves

ON Semiconductor is trading higher in after-market hours, reaching its highest point since Friday's close, while ASE Technology has also advanced.

6 Nov 2026, 23:02 UTC

News
Social Media

Lam Research Corporation announced a $25 billion share buyback program and a quarterly dividend of $0.33, contributing to a significant increase in its stock price.

6 Nov 2026, 23:02 UTC

News

Airbnb reports Q3 revenue growth of 19% to $4.87 billion and EPS of $3.16, exceeding expectations; announces $12 billion buyback program and raises 2026 outlook.

6 Nov 2026, 23:02 UTC

News

A class action lawsuit has been filed against AppLovin Corporation by Kaplan Fox & Kilsheimer LLP, alleging misleading statements about its AI video tool development.

Peer Comparison

Price change

AstraZeneca PLC Forecast

Price Target

By TipRanks

16.74% upside

12 Months Forecast

Average 217.639 USD  16.74%

High 275.899 USD

Low 157.464 USD

Based on 17 Wall Street analysts offering 12 month price targets forAstraZeneca PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

17 ratings

15

Buy

2

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
help-icon Live chat